Keratitis
📧 Sign up to get email alerts when something new happens for Keratitis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-15EMA Authorised: Verkazia (ciclosporin) — Santen Oy
EMA has authorised Verkazia (ciclosporin) from Santen Oy for the treatment of conjunctivitis and keratitis. The product has orphan medicinal…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Pattern of Microbial Keratitis in Assiut University Hospital
Clinical trial update on the pattern of microbial keratitis at Assiut University Hospital; the study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Complex Ocular Infection, Optimization of Microbiological Diagnosis
This clinical trial update from Assistance Publique - Hôpitaux de Paris focuses on complex ocular infections and optimizing microbiological …
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: 3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis [NA]
A completed 3-month study comparing Cationorm Pro with Vismed in adults with dry eye disease related to keratitis or keratoconjunctivitis.
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: 3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis [NA]
Clinical trial comparing Alocross with Vismed in adults with dry eye disease related to keratitis or keratoconjunctivitis is currently activ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Automated Quantitative Ulcer Analysis Study
This update reports on a completed University of Michigan clinical trial studying automated quantitative ulcer analysis for keratitis.
-
FDA approval · 2025-04-07FDA Approved: TOBRAMYCIN AND DEXAMETHASONE — Supplemental Application (Sandoz Inc)
Supplemental FDA approval for tobramycin and dexamethasone (Sandoz) as an ophthalmic combination product.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: The Effects of a Large Language Model on Clinical Questioning Skills [NA]
This completed clinical trial from Sun Yat-sen University evaluated the impact of a large language model on clinicians' questioning skills a…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis [Phase 2]
Phase 2 clinical trial evaluating LV-Visio-AMTRIX, a biological lens made from amniotic membrane, for treatment-resistant keratitis has been…
-
EMA approval · 2024-10-25EMA Authorised: Oxervate (recombinant human nerve growth factor) — Dompe' Farmaceutici S.p.A.
The EMA authorised Oxervate (cenegermin), a recombinant human nerve growth factor, for keratitis, with orphan designation and accelerated as…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: 3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin) [Phase 3]
A Phase 3 study evaluating Ikervis (ciclosporin ophthalmic emulsion) in dry eye disease with severe keratitis has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Safety of Overnight Corneal Reshaping Lenses
A completed clinical trial update summarizes safety findings for overnight corneal reshaping (orthokeratology) lenses used to treat myopia. …
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis [Phase 4]
Phase 4 clinical trial evaluating IKERVIS eye drops administered once daily for quality of vision in dry eye disease patients with severe ke…
-
FDA approval · 2024-01-09FDA Approved: FLUOROMETHOLONE OPHTHALMIC SUSPENSION — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC’s fluorometholone ophthalmic suspension under an Original Application (ANDA216348).
-
FDA approval · 2023-07-21FDA Approved: NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for Neomycin sulfate, polymyxin B sulfate, and dexamethasone ophthalmic suspension from Bausch & Lom…
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis [Phase 3]
Phase 3 clinical trial evaluating ozone-based eye drops as adjuvant therapy for keratitis is in progress with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers [Phase 2, Phase 3]
Phase 2/3 trial update evaluating the safety and effectiveness of the PXL Platinum 330 System with riboflavin solution for refractory cornea…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers [Phase 2, Phase 3]
Clinical trial update on the PXL Platinum 330 System with riboflavin for corneal ulcers, involving Phase 2 and Phase 3, evaluating safety an…
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Impact of Acthar on Everyday Life of Participants With Severe Keratitis [Phase 4]
Phase 4 trial updating on the impact of Acthar on daily living for participants with keratitis.
-
FDA approval · 2021-05-14FDA Approved: MAXITROL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for MAXITROL (neomycin sulfate, polymyxin B sulfate and dexamethasone), updating labeling for this o…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Efficacy and Safety of Ikervis Under Controlled Environmental Conditions Environment [Phase 4]
Phase 4 clinical trial updating the efficacy and safety of Ikervis under controlled environmental conditions for dry eye conditions.
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis [Phase 3]
Phase 3 multicenter trial update on PACK-CXL for infectious keratitis concluded.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. [Phase 1, Phase 2]
Clinical trial evaluating safety and efficacy of rhNGF in stage 2–3 neurotrophic keratitis completed with results posted in 2019.
-
FDA approval · 2019-04-19FDA Approved: TOBRAMYCIN OPHTHALMIC SOLUTION — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Tobramycin Ophthalmic Solution from Alembic Pharmaceuticals Inc. under an original generic application (ANDA).
-
FDA approval · 2018-06-06FDA Approved: PRED MILD — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for PRED MILD (prednisolone acetate) by Allergan, Inc., adding a supplemental approval for this opht…